Pancreatic Cancer Research

ResearcherHarbin Medical UniversityActive in the last 2 years

Long Cheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7255-5668; OpenAlex author ID A5017982357. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. The lncRNA ST18-AS1 suppresses pancreatic cancer progression by enhancing ST18 mRNA stability through anchoring FUS in the cytoplasm. Co-author DOI 10.1038/s41388-025-03455-4↗
  2. Negative correlation of ITCH E3 ubiquitin ligase and miRNA-106b dictates metastatic progression in pancreatic cancer. Co-author DOI 10.18632/oncotarget.6395↗
  3. Perifosine inhibits S6K1-Gli1 signaling and enhances gemcitabine-induced anti-pancreatic cancer efficiency. Co-author DOI 10.1007/s00280-014-2397-9↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yan Jin · 1 shared paper, 2025 · strength 0.24
  2. Gang Wang · 1 shared paper, 2025 · strength 0.24
  3. Yilong Li · 1 shared paper, 2025 · strength 0.24
  4. Zhu-lin Luo · 1 shared paper, 2016 · strength 0.06
  5. Lijun Tang · 1 shared paper, 2016 · strength 0.06
  6. Ruiwu Dai · 1 shared paper, 2016 · strength 0.06
  7. Ying Xin · 1 shared paper, 2014 · strength 0.06
  8. Defei Hong · 1 shared paper, 2014 · strength 0.06
  9. Bin Chen · 1 shared paper, 2014 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.